The article recommends three mature dividend-paying stocks for long-term investors: Coca-Cola (KO) with a 2.64% yield and 64 consecutive years of dividend increases, Lowe's (LOW) with a 2.2% yield despite recent sluggish same-store sales growth, and Procter & Gamble (PG) with a 2.98% yield and an impressive 70-year streak of consecutive dividend increases. While these stocks are unlikely to deliver market-beating returns, they offer steady income streams and proven resilience through economic cycles.

Vanguard research suggests value-oriented stocks may outperform tech stocks over the next 5-10 years. The Vanguard High Dividend Yield ETF (VYM), holding 608 large-cap dividend-paying stocks, has delivered 29.5% returns over the past year with a low 0.04% expense ratio and 2.24% dividend yield. The fund offers exposure to quality blue-chip companies like JPMorgan Chase and Johnson & Johnson, though investors should note its concentration risk with Broadcom representing 8% of assets.

The global laundry detergents market is projected to grow from USD 79.2 billion in 2025 to USD 131.49 billion by 2035, with a CAGR of 5.20%. Growth is driven by increasing demand for liquid detergents and single-dose pods, premiumization of fabric care products, and expansion in e-commerce distribution. The U.S. market is expected to reach USD 23.24 billion by 2035, while Europe hits USD 33.54 billion, with North America as the fastest-growing region.

With recession concerns rising due to high energy prices and consumer budget tightening, investors should consider adding resilient stocks from consumer staples and healthcare sectors to their portfolios. Four dividend-paying companies recommended for recession-resistant income are Coca-Cola, Procter & Gamble, Johnson & Johnson, and Medtronic, all of which have strong track records of maintaining dividends through economic downturns.

Walmart's stock dropped over 9% following its Q1 earnings due to cautious guidance and concerns about higher fuel costs, despite meeting expectations. However, the article argues this presents a buying opportunity given Walmart's 53-year dividend increase streak, strong growth in Walmart+, advertising revenue (up 36%), and management's optimism about future business potential.

The article compares Procter & Gamble and Clorox as defensive dividend stocks for 2026. While Clorox offers a higher dividend yield of 5.1% versus P&G's 2.9%, P&G is recommended as the better buy due to its significantly stronger free cash flow generation ($3.0 billion quarterly vs. Clorox's $761 million annually), superior financial health, and greater ability to sustain and grow dividends. Both companies face customer concentration risks and competitive pressures, but P&G's scale and profitability make it the more reliable choice for dividend investors.

Target is highlighted as a top dividend growth stock and Dividend King with 54 consecutive years of dividend raises. The company offers a 3.6% dividend yield and is demonstrating recovery progress with a new CEO implementing a growth strategy focused on merchandise assortment, store revitalization, and technology acceleration. Recent earnings showed 6.7% year-over-year sales growth and improved guidance.

Green Thumb Industries is adopting Procter & Gamble's business playbook by building a diversified portfolio of branded cannabis products, maintaining consistent quality through standardized production facilities, and operating in limited-license states to build competitive moats. Unlike many cannabis companies, Green Thumb is profitable with a healthy balance sheet. However, it still faces structural challenges including federal illegality, over-the-counter trading, and no dividend, though recent cannabis reclassification to Schedule III could be a major catalyst.

Johnson & Johnson is highlighted as a superior Dividend King investment compared to peers like Procter & Gamble, offering better dividend growth (5.7% vs 2.4% annualized) and business resilience. Despite trading at a premium valuation, J&J's diversified pharmaceutical and medical device portfolio, patent protections, and essential healthcare products make it well-positioned to weather economic uncertainty.

Chevron CEO Mike Wirth warns of imminent physical gas shortages due to potential Strait of Hormuz closure from the Iran war, comparing the impact to 1970s OPEC embargo. As strategic reserves deplete, economies will slow and energy costs will ripple across sectors—benefiting oil companies but hurting transportation, consumer products, and discretionary goods makers.

As investors shift from tech stocks to lower-risk investments, three dividend growth stocks are recommended: AbbVie, a Dividend King pharma company with a 3.2% yield and strong new drug pipeline; Procter & Gamble, a consumer staples Dividend King with a 3% yield trading below historical valuations; and Enterprise Products Partners, an energy infrastructure MLP with a 5.5% yield and 27 consecutive years of distribution increases.

The global facial serum market is projected to grow from US$5.0 billion in 2025 to US$7.2 billion by 2032, with a CAGR of 5.2%. Growth is driven by innovations in formulations, personalization through AI-driven skin analysis, clean beauty trends, and expansion of e-commerce channels. Anti-aging serums are expected to reach US$1.8 billion by 2032, while China is forecasted to grow at 8.1% CAGR.